HEMATOPOIETIC PROGENITOR CELLS OF TRANSGENIC MICE WITH INCREASED COPPER/ZINC SUPEROXIDE-DISMUTASE ACTIVITY ARE RESISTANT TO TUMOR-NECROSIS-FACTOR

被引:14
作者
SAKASHITA, A
EPSTEIN, CJ
CARLSON, E
KOEFFLER, HP
机构
[1] UNIV CALIF LOS ANGELES, CEDARS SINAI MED CTR, SCH MED, DIV HEMATOL ONCOL, LOS ANGELES, CA 90034 USA
[2] UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, DIV MED GENET, SAN FRANCISCO, CA 94143 USA
关键词
D O I
10.1002/jcp.1041600204
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mechanism of growth inhibition mediated by tumor necrosis factor (TNF) is unclear. Since recent data strongly suggested that generation of superoxide is a key step in cytotoxicity of TNF, we reasoned that cells expressing high levels of enzymes that degrade superoxide radicals would be resistant to TNF. Therefore, we examined the TNF-sensitivity of bone marrow progenitor cells of transgenic mice that expressed the gene for human copper zinc-superoxide dismutase (CuZn-SOD). The CuZn-SOD is a key enzyme in the metabolism of superoxide radicals. Heterozygous and homozygous transgenic mice had 3- and 5-fold increased levels of CuZn-SOD activity, respectively. Bone marrow cells of transgenic and nontransgenic mice were plated in soft gel culture with TNF (0.01-100 ng/ml). TNF inhibited myeloid colony formation supported by either granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF from nontransgenic mice in a dose-dependent manner. In contrast, the myeloid clonal growth of homozygote transgenic mice was not inhibited by TNF at concentrations up to 100 ng/ml. As expected, the effects of TNF on erythroid clonogenic cells, which do not produce superoxide, and the action of transforming growth factor-beta on myeloid progenitor cells, were similar in both transgenic and nontransgenic mice. These results suggest that the mechanism of TNF-mediated growth inhibition of hematopoietic cells occurs through production of superoxide. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 37 条
[1]   ASPECTS OF THE STRUCTURE, FUNCTION, AND APPLICATIONS OF SUPEROXIDE-DISMUTASE [J].
BANNISTER, JV ;
BANNISTER, WH ;
ROTILIO, G .
CRC CRITICAL REVIEWS IN BIOCHEMISTRY, 1987, 22 (02) :111-180
[2]  
BROXMEYER HE, 1986, J IMMUNOL, V136, P4487
[3]  
CADET JL, 1994, J NEUROCHEM, V62, P380
[4]   COLD-INDUCED BRAIN EDEMA AND INFARCTION ARE REDUCED IN TRANSGENIC MICE OVEREXPRESSING CUZN-SUPEROXIDE DISMUTASE [J].
CHAN, PH ;
YANG, GY ;
CHEN, SF ;
CARLSON, E ;
EPSTEIN, CJ .
ANNALS OF NEUROLOGY, 1991, 29 (05) :482-486
[5]   TRANSGENIC MICE WITH INCREASED CU/ZN-SUPEROXIDE DISMUTASE ACTIVITY - ANIMAL-MODEL OF DOSAGE EFFECTS IN DOWN-SYNDROME [J].
EPSTEIN, CJ ;
AVRAHAM, KB ;
LOVETT, M ;
SMITH, S ;
ELROYSTEIN, O ;
ROTMAN, G ;
BRY, C ;
GRONER, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :8044-8048
[6]  
Fridovich, 1976, FREE RADICALS BIOLOG, V1, P239
[7]   TUMOR NECROSIS FACTORS - GENE STRUCTURE AND BIOLOGICAL-ACTIVITIES [J].
GOEDDEL, DV ;
AGGARWAL, BB ;
GRAY, PW ;
LEUNG, DW ;
NEDWIN, GE ;
PALLADINO, MA ;
PATTON, JS ;
PENNICA, D ;
SHEPARD, HM ;
SUGARMAN, BJ ;
WONG, GHW .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1986, 51 :597-609
[8]   COMPLEMENTARY-DNA CLONING OF A RECEPTOR FOR TUMOR-NECROSIS-FACTOR AND DEMONSTRATION OF A SHED FORM OF THE RECEPTOR [J].
HELLER, RA ;
SONG, K ;
ONASCH, MA ;
FISCHER, WH ;
CHANG, D ;
RINGOLD, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (16) :6151-6155
[9]   MODULATION OF TUMOR-NECROSIS-FACTOR-ALPHA CYTOTOXICITY IN L929 CELLS BY BACTERIAL TOXINS, HYDROCORTISONE AND INHIBITORS OF ARACHIDONIC-ACID METABOLISM [J].
HEPBURN, A ;
BOEYNAEMS, JM ;
FIERS, W ;
DUMONT, JE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) :815-822
[10]   RELATIONSHIP OF RESISTANCE TO OXYGEN FREE-RADICALS TO CUZN-SUPEROXIDE DISMUTASE ACTIVITY IN TRANSGENIC, TRANSFECTED, AND TRISOMIC CELLS [J].
HUANG, TT ;
CARLSON, EJ ;
LEADON, SA ;
EPSTEIN, CJ .
FASEB JOURNAL, 1992, 6 (03) :903-910